Periconceptual multi-micronutrient supplementation and placental function in rural Gambian women

ISRCTN ISRCTN13687662
DOI https://doi.org/10.1186/ISRCTN13687662
Secondary identifying numbers SCC 1000
Submission date
21/07/2005
Registration date
15/08/2005
Last edited
13/11/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Stephen Owens
Scientific

MRC Laboratories
P.O. Box 273
Fajara
-
Gambia

Phone +220 9812617
Email sowens@mrc.gm

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titlePericonceptual multi-micronutrient supplementation and placental function in rural Gambian women: a randomised controlled trial
Study acronymPMMST
Study objectivesImproved maternal micronutrient status prior to conception and during early pregnancy results in improved placental growth and functional parameters, relevant to fetal growth and physiological development.
Ethics approval(s)Medical Research Council (MRC) and the Gambian Government Ethics Committee, 13/03/2006, reference numbers: SCC1000 and L2005.111, respectively
Health condition(s) or problem(s) studiedFetal growth restriction
InterventionUNICEF Maternal multi-micronutrient supplement (UNIMMAP)
Placebo
Intervention typeSupplement
Primary outcome measure1. The ratio of plasminogen activator inhibitor-1 (PAI-1) to plasminogen activator inhibitor-2 (PAI-2) at 20 weeks gestation
2. Placental doppler flows at 20 weeks
3. Placental transfer of pathogen specific IgG at delivery

Primary outcomes amended from the following on 20/03/2006:
1. Placental volume at 20 weeks gestation
2. Placental doppler flows at 20 weeks
3. Placental transfer of pathogen specific IgG at delivery
Secondary outcome measures1. Maternal serum human chorionic gonadotropin (hCG) and human placental lactogenic (hPL) concentration at 20 weeks
2. The ratio of PAI-1 to PAI-2 at 30 weeks, and at delivery
3. Placental doppler waveforms at 30 weeks
4. Change in maternal haematological status from baseline to 20 and 30 weeks gestation, and at delivery
5. Change in maternal micronutrient status from baseline to 20 and 30 weeks gestation, and at delivery
6. Fetal anthropometry at 20, 30 weeks and at delivery
7. Placental weight at delivery

Secondary outcomes amended from the following as of 20/03/2006:
1. Placental endocrine function (hCG; hPL) at 20 weeks
2. Placental volume at 30 weeks
3. Placental doppler waveforms at 30 weeks
4. Fetal anthropometry at 20, 30 weeks and at delivery
5. Placental weight at delivery
6. Placental transport function (essential amino acids) at delivery
Overall study start date01/09/2005
Completion date30/03/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants3000
Key inclusion criteriaWomen of reproductive age (17 years to 45 years) living in West Kiang, The Gambia.
The age inclusion criteria was previously 15 to 45 years of age, amendment date: 20/03/2006
Key exclusion criteria1. Women known to be already pregnant
2. Women breastfeeding infants less than 1 year of age
3. Women found to be severely anaemic at recruitment (haemoglobin concentration <7 g/dl)
Date of first enrolment01/09/2005
Date of final enrolment30/03/2008

Locations

Countries of recruitment

  • Gambia

Study participating centre

MRC Laboratories
Fajara
-
Gambia

Sponsor information

Medical Research Council (MRC) International Nutrition Group (UK)
Research council

London School of Hygiene and Tropical Medicine
London
WC1E 7HT
United Kingdom

Email andrew.prentice@lshtm.ac.uk
ROR logo "ROR" https://ror.org/03x94j517

Funders

Funder type

Research council

Medical Research Council (UK) International Nutrition Group Core Funding
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2015 Yes No